Nancy Garren
- Genetics top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Co-authors
- Paul DuicJohn A. ButmanKevin CamphausenPaul S. AlbertHoward A. FineKraig MooreJohn ParkTeri Kreisl
- Topics
- Glioma Diagnosis and Treatment (4 papers)Cancer Treatment and Pharmacology (2 papers)Brain Metastases and Treatment (2 papers)
- Cited by
- GeneticsCancer ResearchNeurology
- Partner nations
- United States
In The Last Decade
Nancy Garren
4 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Genetics 1.0k
- Pulmonary and Respiratory Medicine 396
- Molecular Biology 361
- Cancer Research 331
- Oncology 266
Countries citing papers authored by Nancy Garren
This map shows the geographic impact of Nancy Garren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Garren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Garren more than expected).
Fields of papers citing papers by Nancy Garren
This network shows the impact of papers produced by Nancy Garren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Garren. The network helps show where Nancy Garren may publish in the future.
Co-authorship network of co-authors of Nancy Garren
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Garren. A scholar is included among the top collaborators of Nancy Garren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Garren. Nancy Garren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 31 | |
| 3 | 3 | |
| 4 | Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastomabreakdown → | 1211 |
About Nancy Garren
Nancy Garren is a scholar working on Genetics, Modeling and Simulation and Biotechnology, having authored 4 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Genetics (1.0k citations), Cancer Research (331 citations) and Neurology (202 citations). Nancy Garren has collaborated with scholars based in United States. Frequent co-authors include Paul Duic, John A. Butman, Kevin Camphausen, Paul S. Albert, Howard A. Fine, Kraig Moore, John Park, Teri Kreisl, Lyndon Kim and Megan Mackey. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.